Guideline development for prevention of transfusion-associated graft-versus-host disease: reduction of indications for irradiated blood components after prestorage leukodepletion of blood components.

MLA

Wiersum-Osselton, Johanna C., et al. “Guideline Development for Prevention of Transfusion-Associated Graft-versus-Host Disease: Reduction of Indications for Irradiated Blood Components after Prestorage Leukodepletion of Blood Components.” British Journal of Haematology, vol. 195, no. 5, Dec. 2021, pp. 681–88. EBSCOhost, https://doi.org/10.1111/bjh.17822.

APA

Wiersum-Osselton, J. C., Slomp, J., Frederik Falkenburg, J. H., Geltink, T., van Duijnhoven, H. L. P., Netelenbos, T., & Schipperus, M. R. (2021). Guideline development for prevention of transfusion-associated graft-versus-host disease: reduction of indications for irradiated blood components after prestorage leukodepletion of blood components. British Journal of Haematology, 195(5), 681–688. https://doi.org/10.1111/bjh.17822

Chicago

Wiersum-Osselton, Johanna C, Jennichjen Slomp, J H Frederik Falkenburg, Tessa Geltink, Hans L P van Duijnhoven, Tanja Netelenbos, and Martin R Schipperus. 2021. “Guideline Development for Prevention of Transfusion-Associated Graft-versus-Host Disease: Reduction of Indications for Irradiated Blood Components after Prestorage Leukodepletion of Blood Components.” British Journal of Haematology 195 (5): 681–88. doi:10.1111/bjh.17822.